|
|
|
|
Molecular Pharmacology, Vol 16, 473-481, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Physiology, University of Connecticut Health Center, Farmington, Connecticut 06032
Addition of the synthetic chemotactic peptide, fMet-Leu-Phe, to rabbit neutrophils elevates the basal level of cyclic 3',5'-AMP. Stimulation of the cyclic AMP level reaches a maximum at 1 min (60% increase over basal value at 5 nM fMet-Leu-Phe) and subsequently the cyclic AMP level returns to the basal value within 5 min. In the absence of extracellular Ca2+, the cyclic AMP level increases minimally (<20%) upon exposure to fMet-Leu-Phe. The effect of fMet-Leu-Phe is detectable at 0.5 nM and increases at higher concentrations. Inhibition of the cyclic AMP-dependent phosphodiesterase activity by pretreatment with 1-methyl-3-isobutylxanthine enhances both the basal and stimulated cyclic AMP levels.
Note:
ACKNOWLEDGMENTS
We thank Dr. P. H. Naccache for many timely
discussions and Dr. M. C. Wacholtz for helpful information in the course of this work. We also thank Dr.
R. J. Freer for supplying the chemotactic peptide.
This article has been cited by other articles:
![]() |
N. Thibault, C. Burelout, D. Harbour, P. Borgeat, P. H. Naccache, and S. G. Bourgoin Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes J. Leukoc. Biol., February 1, 2002; 71(2): 367 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Pozzan, D. Lew, C. Wollheim, and R. Tsien Is cytosolic ionized calcium regulating neutrophil activation? Science, September 30, 1983; 221(4618): 1413 - 1415. [Abstract] [PDF] |
||||